99,702 Shares in Avantor, Inc. (NYSE:AVTR) Acquired by Bank of Montreal Can

Bank of Montreal Can acquired a new position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 99,702 shares of the company's stock, valued at approximately $2,575,000.

Several other large investors also recently made changes to their positions in AVTR. Blue Trust Inc. lifted its holdings in shares of Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock valued at $31,000 after acquiring an additional 1,391 shares in the last quarter. UMB Bank n.a. acquired a new position in shares of Avantor during the third quarter worth about $49,000. Nisa Investment Advisors LLC boosted its position in shares of Avantor by 69.6% in the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock worth $53,000 after buying an additional 835 shares during the period. GAMMA Investing LLC boosted its position in shares of Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock worth $70,000 after buying an additional 1,285 shares during the period. Finally, ORG Partners LLC raised its holdings in shares of Avantor by 5,773.0% during the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company's stock valued at $122,000 after buying an additional 5,773 shares during the period. Institutional investors and hedge funds own 95.08% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Royal Bank of Canada restated an "outperform" rating and issued a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Barclays decreased their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research note on Friday, October 25th. Robert W. Baird dropped their price target on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research note on Monday, October 28th. Wells Fargo & Company decreased their price objective on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Monday, October 28th. Finally, UBS Group lowered their target price on Avantor from $30.00 to $29.00 and set a "buy" rating for the company in a research note on Tuesday, October 8th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $27.57.

Avantor Stock Performance

AVTR stock traded up $0.55 during trading on Friday, hitting $21.39. 5,379,970 shares of the company's stock traded hands, compared to its average volume of 6,484,929. The stock has a market capitalization of $14.56 billion, a price-to-earnings ratio of 46.50, a price-to-earnings-growth ratio of 2.56 and a beta of 1.29. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00. The stock has a fifty day moving average price of $22.87 and a two-hundred day moving average price of $23.62. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.